| RS2521167101 |
GRIA3
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability 94, Syndromic X-linked intellectual disability 94 |
| RS2521169015 |
GRIA3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2521173320 |
GRIA3
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability 94, Syndromic X-linked intellectual disability 94 |
| RS2521177673 |
ACSL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2521178978 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2521179205 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521182259 |
SLC9A6
|
Health Risk |
Likely pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2521197429 |
CUL4B
|
Health Risk |
Pathogenic |
X-linked intellectual disability Cabezas type, X-linked intellectual disability Cabezas type |
| RS2521198322 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521198629 |
CUL4B
|
Health Risk |
Pathogenic |
X-linked intellectual disability Cabezas type, X-linked intellectual disability Cabezas type |
| RS2521199896 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521200386 |
CUL4B
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability Cabezas type, X-linked intellectual disability Cabezas type |
| RS2521203628 |
BGN
|
Health Risk |
Likely pathogenic |
Meester-Loeys syndrome, Meester-Loeys syndrome |
| RS2521208825 |
GRIA3
|
Health Risk |
Pathogenic |
— |
| RS2521210921 |
HDAC8
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS2521213669 |
HDAC8
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Cornelia de Lange syndrome 5 |
| RS2521213722 |
BGN
|
Health Risk |
Likely pathogenic |
— |
| RS2521216920 |
AMER1
|
Health Risk |
Likely pathogenic |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |
| RS2521219168 |
BGN
|
Health Risk |
Likely pathogenic |
Meester-Loeys syndrome, Meester-Loeys syndrome |
| RS2521219756 |
SLC9A6
|
Health Risk |
Likely pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2521221582 |
AMER1
|
Health Risk |
Likely pathogenic |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |
| RS2521223304 |
AMER1
|
Health Risk |
Pathogenic |
— |
| RS2521224064 |
AMER1
|
Health Risk |
Pathogenic |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |
| RS2521226623 |
AMER1
|
Health Risk |
Pathogenic |
— |
| RS2521227899 |
BGN
|
Health Risk |
Likely pathogenic |
Meester-Loeys syndrome, Meester-Loeys syndrome |
| RS2521230309 |
RBM10
|
Health Risk |
Likely pathogenic |
— |
| RS2521231477 |
ACSL4
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 63 |
| RS2521233986 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2521237559 |
GRIA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Syndromic X-linked intellectual disability 94, Syndromic X-linked intellectual disability 94 |
| RS2521237636 |
GRIA3
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2521237702 |
GRIA3
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability 94, Syndromic X-linked intellectual disability 94 |
| RS2521237781 |
GRIA3
|
Health Risk |
Pathogenic |
— |
| RS2521237833 |
GRIA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndromic X-linked intellectual disability 94, Syndromic X-linked intellectual disability 94 |
| RS2521246350 |
FHL1
|
Health Risk |
Likely pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2521247887 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2521249838 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS2521249957 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521250676 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2521251058 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521251181 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS2521253235 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521263548 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2521264630 |
FHL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2521265963 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2521266207 |
FHL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2521274472 |
GALE
|
Health Risk |
Pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS2521282912 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2521285775 |
GALE
|
Health Risk |
Pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS2521286102 |
FHL1
|
Health Risk |
Pathogenic |
Myopathy, reducing body |
| RS2521287361 |
FHL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2521287431 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2521288079 |
GALE
|
Health Risk |
Likely pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS2521288550 |
GALE
|
Health Risk |
Pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS2521288727 |
GALE
|
Health Risk |
Pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS2521289319 |
MCTS1
|
Health Risk |
Pathogenic |
Immunodeficiency 118, Immunodeficiency 118 |
| RS2521290553 |
MCTS1
|
Health Risk |
Pathogenic |
Immunodeficiency 118, Immunodeficiency 118 |
| RS2521290612 |
MCTS1
|
Health Risk |
Pathogenic |
Immunodeficiency 118, Immunodeficiency 118 |
| RS2521292161 |
GALE
|
Health Risk |
Likely pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS2521294004 |
GALE
|
Health Risk |
Pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS2521300616 |
FHL1
|
Health Risk |
Likely pathogenic |
Myopathy, reducing body |
| RS2521303090 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2521310108 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2521310197 |
SLC9A6
|
Health Risk |
Likely pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2521310914 |
GALE
|
Health Risk |
Likely pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS2521317854 |
PRPS1
|
Health Risk |
Likely pathogenic |
— |
| RS2521317897 |
FOXE3
|
Health Risk |
Pathogenic |
Congenital primary aphakia, Anterior segment dysgenesis |
| RS2521318388 |
FOXE3
|
Health Risk |
Likely pathogenic |
FOXE3-related disorder, FOXE3-related disorder |
| RS2521319607 |
GALE
|
Health Risk |
Pathogenic |
Thrombocytopenia 13, syndromic |
| RS2521320879 |
GALE
|
Health Risk |
Pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS2521321260 |
NAA10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2521321688 |
FOXE3
|
Health Risk |
Pathogenic |
Congenital primary aphakia, Anterior segment dysgenesis |
| RS2521322039 |
FOXE3
|
Health Risk |
Likely pathogenic |
— |
| RS2521323759 |
FOXE3
|
Health Risk |
Pathogenic |
Congenital primary aphakia, Congenital primary aphakia |
| RS2521326158 |
GALE
|
Health Risk |
Pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS2521326203 |
GALE
|
Health Risk |
Pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS2521331057 |
C1GALT1C1
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome, Hemolytic uremic syndrome |
| RS2521331868 |
C1GALT1C1
|
Health Risk |
Likely pathogenic |
Abnormal protein O-linked glycosylation, Hemolytic uremic syndrome |
| RS2521331985 |
GRIA3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2521333666 |
SLC9A6
|
Health Risk |
Likely pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2521333744 |
SLC9A6
|
Health Risk |
Likely pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2521333750 |
GRIA3
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 94, Syndromic X-linked intellectual disability 94 |
| RS2521333836 |
GRIA3
|
Health Risk |
Likely pathogenic |
GRIA3-related disorder, GRIA3-related disorder |
| RS2521335635 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2521336101 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2521336794 |
PRPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Arts syndrome |
| RS2521336817 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2521336988 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2521337446 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, Thyroid cancer |
| RS2521337625 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2521342044 |
PRPS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2521342152 |
PRPS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2521345872 |
PRPS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2521345889 |
PRPS1
|
Health Risk |
Likely pathogenic |
Hearing loss, X-linked 1 |
| RS2521349816 |
PRPS1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease X-linked recessive 5, Charcot-Marie-Tooth disease X-linked recessive 5 |
| RS2521354962 |
GPC3
|
Health Risk |
Likely pathogenic |
Simpson-Golabi-Behmel syndrome type 1, Nonpapillary renal cell carcinoma |
| RS2521356554 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS2521361687 |
FMR1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2521364194 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521380537 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521380983 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |